These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37794425)

  • 1. The association between history of retained placenta and success rate of misoprostol treatment for early pregnancy failure.
    Cohen A; Gutman-Ido E; Karavani G; Albeck A; Rosenbloom JI; Shushan A; Chill HH
    BMC Womens Health; 2023 Oct; 23(1):523. PubMed ID: 37794425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Arch Gynecol Obstet; 2020 Nov; 302(5):1279-1296. PubMed ID: 32638095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expectant vs medical management for retained products of conception after medical termination of pregnancy: a randomized controlled study.
    Tzur Y; Berkovitz-Shperling R; Goitein Inbar T; Bar-On S; Gil Y; Levin I; Cohen A
    Am J Obstet Gynecol; 2022 Oct; 227(4):599.e1-599.e9. PubMed ID: 35752301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
    Sonalkar S; Koelper N; Creinin MD; Atrio JM; Sammel MD; McAllister A; Schreiber CA
    Am J Obstet Gynecol; 2020 Oct; 223(4):551.e1-551.e7. PubMed ID: 32305259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study.
    Ehrnstén L; Altman D; Ljungblad A; Kopp Kallner H
    Acta Obstet Gynecol Scand; 2020 Apr; 99(4):488-493. PubMed ID: 31784973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
    Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal misoprostol in management of retained placenta: a contradictory result.
    Pongsatha S; Tongsong T
    J Med Assoc Thai; 2011 May; 94(5):535-9. PubMed ID: 21675440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment with misoprostol for early failure of pregnancies after assisted reproductive technology: a promising treatment option.
    Machtinger R; Stockheim D; Seidman DS; Lerner-Geva L; Dor J; Schiff E; Shulman A
    Fertil Steril; 2009 May; 91(5):1881-5. PubMed ID: 18455163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal administration of misoprostol for the management of retained placenta--a preliminary report.
    Li YT; Yin CS; Chen FM
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Dec; 64(12):721-4. PubMed ID: 11922493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting the Success of Repeated Misoprostol Course for the Treatment of Missed Abortion.
    Bar-Noy T; Nahshon C; Abu Nasra L; Ostrovsky L; Sagi-Dain L
    J Gynecol Obstet Hum Reprod; 2022 Dec; 51(10):102477. PubMed ID: 36103968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of misoprostol in relation to uterine position in the treatment of early pregnancy failure.
    Reif P; Tappauf C; Panzitt T; Haas J; Lang U; Klaritsch P
    Int J Gynaecol Obstet; 2013 May; 121(2):137-40. PubMed ID: 23419998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical vs. surgical evacuation of first-trimester spontaneous abortion.
    Moodliar S; Bagratee JS; Moodley J
    Int J Gynaecol Obstet; 2005 Oct; 91(1):21-6. PubMed ID: 16051242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive outcome after early pregnancy loss treated with misoprostol versus surgical aspiration.
    Mizrachi Y; Ben-Ezry E; Kleiner I; Friedman G; Kerner R; Bar J; Raziel A; Weissman A; Sagiv R
    Reprod Biomed Online; 2020 Oct; 41(4):707-713. PubMed ID: 32819838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of first trimester miscarriage: a prospective cohort study in a large tertiary care center in Northern Italy.
    Lazzarin S; Crippa I; Vaglio Tessitore I; Ornaghi S; Vergani P
    J Matern Fetal Neonatal Med; 2022 Jan; 35(1):110-115. PubMed ID: 31937151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between uterine position and transvaginal misoprostol treatment for early pregnancy failure.
    Chill HH; Malyanker N; Karavani G; Haj-Yahya R; Herzberg S; Bahar R; Shveiky D; Dior UP
    J Obstet Gynaecol Res; 2018 Feb; 44(2):248-252. PubMed ID: 29094502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery.
    Sundaram S; Diaz JP; González-Quintero VH; Verma U
    Am J Obstet Gynecol; 2009 May; 200(5):e24-6. PubMed ID: 19136084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of incomplete abortion related to treatment modality.
    Sharvit M; Yagur Y; Shams R; Daykan Y; Klein Z; Schonman R
    Arch Gynecol Obstet; 2023 Nov; 308(5):1543-1548. PubMed ID: 37653249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.